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Available online 24 February 2013AbstractIn experimental Trypanosoma cruzi infections, severe thymic atrophy leads to release of activated CD4þCD8þ double-positive (DP) T cells
to the periphery. In humans, activated DP T cells are found in the blood in association with severe cardiac forms of human chronic Chagas
disease. The mechanisms underlying the premature thymocyte release during the chagasic thymic atrophy remain elusive. We tested whether the
migratory properties of intrathymic thymocytes are modulated by the parasite trans-sialidase (TS). We found that TS affected the dynamics of
thymocytes undergoing intrathymic maturation, and these changes were accompanied by an increase in the number of recent DP thymic em-
igrants in the peripheral lymphoid organs. We demonstrated that increased percentages of blood DP T cell subsets were associated with
augmented antibody titers against TS in chagasic patients with chronic cardiomyopathy. In vitro studies showed that TS was able to activate the
MAPK pathway and actin filament mobilization in thymocytes. These effects were correlated with its ability to modulate the adhesion of
thymocytes to thymic epithelial cells and their migration toward extracellular matrix. These findings point to effects of TS that could influence
the escape of immature thymocytes in Chagas disease.
 2013 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
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Trypanosoma cruzi is the parasite protozoan responsible for
Chagas disease, which is an important public health burden in
the Americas. According to the Pan American Health Organi-
zation, 20% of Latin America’s population is at risk of infection
[1]. The initial acute phase of the disease is characterized by* Corresponding author.
E-mail address: morrot@micro.ufrj.br (A. Morrot).
1286-4579/$ - see front matter  2013 Institut Pasteur. Published by Elsevier Ma
http://dx.doi.org/10.1016/j.micinf.2013.02.003numerous circulating parasites able to infect several tissues in
the host, including skeletal muscle, lymphoid tissues, nervous
tissues, and glands [2]. It progresses to an indefinite asymp-
tomatic period with almost undetectable blood parasitemia
[3,4]. It has been shown that the events occurring during this
phase are essential for activation of the immune system during
the late chronic phase of the disease [5].
In the murine model of T. cruzi infection, several changes
are observed in lymphoid organs, including the thymus, where
the parasitism occurs [6]. Our studies have revealed an intense
and severe thymic atrophy in acutely infected animals, mainlysson SAS. All rights reserved.
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cytes by apoptosis in the cortical area of the thymus [6,7].
These changes are paralleled by enhanced expression of
extracellular matrix (ECM) molecules, such as laminin and
fibronectin in the thymus, accompanied by phenotypic and
functional alterations of thymic epithelial cells (TECs) [8].
Thymus atrophy is also associated with the release of these
double-positive cells to the periphery, where they have been
found to express potentially autoreactiveTCRs and to acquire an
activated phenotype, similar to what is described for effector/
memory single-positive T cells [9,10]. Most importantly, we
have recently demonstrated that increased percentages of pe-
ripheral blood subsets of DP cells exhibiting an activated HLA-
DRþ phenotype are associated with severe cardiac forms of
human chronicChagas disease [10]. These results suggest thatT.
cruzi infection alters the human thymus, which is already atro-
phic in adult individuals [11], in such a way as to promote an
abnormal release of non-selected thymocytes [5,6].
To date, the mechanisms underlying the infection-induced
thymic disturbance and the escape of immature thymocytes
are not fully understood. However, an important role has been
suggested for the T. cruzi surface protein known as trans-sia-
lidase (TS) [12,13]. Since the protozoan is unable to synthesize
sialic acid de novo, the glycosylphosphatidylinositol-anchored
trans-sialidase allows the parasite to scavenge a-(2,3)-linked
sialyl residues from exogenous glycoconjugates and to transfer
them to mucine-like acceptors covering the parasite surface
[14]. Changes in the sialylation profile of cell surface receptors
by TS are able to induce apoptosis in cells of the immune
system in vivo, including the thymus [15]. A detailed study
using TS-treated animals revealed that these effects also
resulted from apoptosis in the thymic nurse cell complex [16].
The aim of this work was to test whether TS alters the
migratory and adhesive properties of thymocytes undergoing
intrathymic differentiation. To that end, we analyzed whether
the T. cruzi trans-sialidase plays a role in the premature release
of double-positive CD4þCD8þ thymocytes to peripheral
lymphoid organs.
2. Materials and methods2.1. Ethics statementThe study was approved by the Research Ethics Committee
of Fiocruz (protocol CEUA-LW8/10). Protocols for animal
and human studies were approved by the Institutional Ethical
Committees in accordance with international guidelines. All
animal experimentation was performed in accordance with the
terms of the Brazilian guidelines for the animal welfare
regulations.2.2. Study populationHealthy volunteers and T. cruzi chronic chagasic patients
were recruited from Chagas Unit, Hospital Provincial del
Centenario de Rosario, UNR, Argentina. Subjects using any
medication thought to affect immune functions were excludedfrom the study. The diagnosis was based on standard sero-
logical test, including indirect immunofluorescence and hae-
maglutination assay. All chronic-infected patients and non-
infected individuals participated in serological tests to
confirm the diagnosis for T. cruzi infection, with ages ranging
from 30 to 64 years. The seropositive cases included fifteen
cardiac chronic-infected patients presenting dilated cardio-
myopathy diagnosed based in a detailed clinical examination,
including electrocardiography (ECG) and chest X-ray. Addi-
tionally, we included fifteen chagasic patients without any
cardiac alterations detected, being diagnosed as in the inde-
terminate form of the disease. Fifteen sex and age matched-
controls were also included.2.3. Animals and infectionMale BALB/c mice and C57BL/6 TLR4-deficient mice,
aged 4e8 weeks, were obtained respectively from the
Oswaldo Cruz Foundation animal facilities and Federal Uni-
versity of Rio de Janeiro. Acute T. cruzi infection was per-
formed by inoculating the animals intraperitoneally with 102
blood-derived trypomastigote forms of the Tulahuen strain,
after isolation from BALB/c mice. After 2 weeks of acute
infection (in the peak of parasitemia), animals were killed and
the organs to be studied were removed. Blood parasites were
counted using Neubauer’s chambers.2.4. Recombinant trans-sialidase and specific-polyclonal
antibodiesRecombinant TS were obtained from Escherichia coli
MC1061 electrotransformed with plasmids containing the
wild-type TS insert, TSREP.C [17]. The recombinant protein
contained a poly(His) tag for purification as described [18,19],
and was passed through an agarose-immobilized polymyxin B
column (SigmaeAldrich, St. Louis, MO) to obtain an LPS-
free preparation. To generate a polyclonal antibody against
TS, 0.5 ml of the inactive enzyme containing C-terminal re-
peats (500 mg/ml) (obtained as described above) with 0.5 ml of
complete Freund’s adjuvant was used to immunize rabbits.
Serum was separated by centrifugation (2500  g for 10 min)
and immunoglobulin purification was done by using a protein-
A affinity column (Pierce Biotechnology, Inc. USA). The
antiserum specificity was determined by immunoabsorbent
assay (ELISA).2.5. Trans-sialidase intrathymic injectionMice were anaesthetized by intraperitoneal injection of
5 mg/ml of ketamine (Virbac S.A., Rio de Janeiro, Brazil) and
1 mg/ml of xylazine (Bayer Ltd, Rio de Janeiro, Brazil). The
thoracic cavity was opened via a midline incision and 10 mg of
TS or bovine serum albumin (BSA) was injected intrathymi-
cally (10 ml of solution at 0.5 mg/ml for each thymic lobe).
Surgical clips (Becton, Dickinson and Company, USA) were
used to close the thoracic cavity after intrathymic injections.
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evaluated by flow cytometry.2.6. Cell adhesion and transmigration assayThe TEC line was plated onto 25 cm3 culture flasks (Nunc,
Rochester, NY) at a ratio of 7  104 cells/flask for 48 h. TECs
and thymocytes were treated for 30 min with 10 mg/ml of
recombinant TS. Thymocytes were then allowed to adhere to
TEC cultures (50 thymocytes/TEC) for 30 min at 37 C and
for more 30 min at room temperature on a horizontal shaker
(60 rpm). Nonadherent cells were gently washed out with
PBS, and the number of adhered thymocytes per TEC was
then determined by direct counting. Thymocyte migratory
activity was assessed in the Transwell system. Briefly, 5 mm
pore size Transwell plates (Costar; Corning) were coated with
10 mg/ml fibronectin (Chemicon International) or with BSA at
the same concentration for 1 h at 37 C and later blocked with
0.5% BSA-PBS for 45 min at 37 C. Thymocytes were treated
with 10 mg/ml of recombinant TS and then added in the upper
chambers of the transwell chambers. After 3 h of incubation at
37 C in a 5% CO2 humidified atmosphere, migration was
defined by counting the cells that migrated to the lower
chambers by flow cytometer (FACSCalibur, BD).2.7. Isolation of peripheral blood cells (PBMC),
antibodies, flow cytometry and fluorescent-phalloidin
stainingHeparinized whole blood was collected and diluted 1/1
with PBS before separated by density centrifugation on Ficoll-
Hypaque (Sigma) for 30 min at 2000 rpm. All antibodies were
purchased from BD Biosciences (CA, USA). For human T cell
phenotyping, individual samples contained 1  106 living cells
were pre-blocked with human AB serum for 15 min and
stained at 4 C for 30 min simultaneously with three colors
using the following antibodies for FACS analysis: APC-
labeled anti-CD3, APCCy7-labeled anti-CD4 and PECy7-
labeled anti-CD8 antibodies (BD/PharMingen). For murine T
cell phenotyping experiments, thymuses were minced, washed
and resuspended in 5 ml of Fc receptor blocking solution (BD
Pharmingen) for 15 min. The thymocytes were labeled with
Alexa 488-labeled anti-CD4 (Caltag) and PercP-labeled anti-
CD8 (BD Pharmingen) antibodies as described [20]. In order
to verify which thymocytes subsets could be targets of TS,
thymocytes were also incubated with TS-FITC conjugate ob-
tained as described [21]. Analyzes were done after recording
25,000e50,000 events for each sample, using CELLQuest
software (Becton Dickinson). Lymphocytes were gated based
on forward and side scatter parameters, so as to avoid larger
leukocytes such as macrophages and granulocytes. For
fluorescent-phalloidin staining of actin filaments, thymocytes
were left in starvation for 1 h previously to the TS treatment as
described before. The cells were then fixed in para-
formaldehyde 4% at 4 C for 20 min and after permeabiliza-
tion (Perm Wash e BD) were subsequently incubated withphalloidin-FITC (Sigma) and DAPI (Santa Cruz) for immu-
nofluorescence analysis.2.8. ELISAAnti-TS antibodies were quantified in plasma samples from
healthy (n ¼ 10), indeterminate (IND, n ¼ 12) or cardiac
chronic (n ¼ 12) chagasic patients by ELISA. Briefly, Nunc-
Immuno microtiter plates (Roskilde, Denmark) were coated
with 250 ng of TS lacking the immunodominant SAPA repeats
tail (supplied by S. Revelli), blocking with 5% non-fat and
aliquots of 150 mL/well from each patient were then added (by
duplicate). Chagatest reactives (Wiener Lab, Rosario,
Argentina) were used to detect specific antibodies. The plate
was read at 450/545 nm using a Stat Fax 2100 plate reader
(Awareness Technology, USA).2.9. Western blotting analysisThymocytes were left under starvation for 1 h. Later, they
were treated with both forms of recombinant TS for 0, 15 and
30 min. Thymocytes were then lysed in RIPA lysis buffer.
Lysates were centrifuged at 16,000  g for 10 min at 4 C and
the proteins present in the supernatants were solubilized in an
SDS buffer for electrophoresis [10] and fractionated in SDS-
PAGE 9%. The proteins were transferred to PVDF mem-
branes (Trans-Blot system, Bio-Rad) and the membranes were
incubated overnight with anti-p-Tyr, anti-p-ERK and anti-p-
JNK (Cell Signaling), followed by horseradish peroxidase
(HRP)-conjugated anti-mouse secondary antibodies IgG for
ECL quimioluminescence reaction (Amersham-Pharmacia).2.10. Tissue preparation and histochemistryThymuses from TS-injected mice and from infected ani-
mals (15 days post-infection) were fixed in paraformaldehyde
and process for paraffin wax sectioning. Endogenous perox-
idase was blocked with 3% H2O2. The slides were blocked
with a solution containing 8% non-fat dried milk in PBS-
BSA/10%, Tween 0.05%, Triton 0.1%, normal goat serum
20% and normal mice serum 20%. The paraffin sections,
5 mm thick, were labeled with anti-TS polyclonal antibody
(diluted in PBS/BSA 3%, Tween 0.05%, Triton 0.1%, normal
goat serum 10% and normal rabbit serum 10%), overnight at
4 C in a humidified chamber. The sections were washed with
PBS-Tween 0.2% and incubated with anti-rabbit IgG polymer
(for anti-TS labeled sections) diluted in PBS (NICHEREI,
Japan).2.11. Statistical analysisStatistical analyzes were performed with GraphPad Prism 4
software, using one-way ANOVA test. Results were expressed
as mean  standard error (S.E.). Differences between control
vs. treated group were considered statistically significant when
P < 0.05.
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Fig. 2. Intrathymic injection of T. cruzi trans-sialidase induces thymocyte depletion. BALB/c mice were injected with 10 mg of TS, or alternatively PBS or BSA as
control. After 5 days, thymuses were collected and thymocytes were stained with anti-CD4 and anti-CD8 mAbs prior to flow cytometry analysis. The percentages
of double-positive CD4þCD8þ T cells are represented by (A) histograms and (B) dot-plot analysis. Data are representative of three independent experiments, and
are means  S.Ds. of two independent experiments (n ¼ 6 mice per group). *P < 0.05.
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sialidase antigens are present in the T. cruzi-infected
thymus and bind to thymocyte surfacesIntense thymic atrophy is a hallmark of the acute phase of
experimental Chagas disease. This phenomenon is evident by
10 days post-infection after intraperitoneal injection of 102
trypomastigotes into BALB/c mice. The severe thymic atrophy
has been shown to be at least in part due to the activity of the
parasite-derived trans-sialidase [16]. We tested for the parasite
trans-sialidase in the thymus of infected animals using a
specific-polyclonal antibody and detected reactivity 15 days
post-infection, the peak of parasitemia. As shown in Fig. 1A,
the cortical and medullary regions of the thymus of infectedFig. 1. Immunohistochemical evidence of trans-sialidase in thymus in acute T. cru
intraperitoneally with 102 blood-derived trypomastigote forms of the Tuluahuen str
immuno-histochemistry analysis with a polyclonal antibody against T. cruzi trans-s
polyclonal anti-TS and streptavidin (upper left panel), or streptavidin only (upper ri
for TS. Bars ¼ 40 mm. Data are representative of two independent experiments using
were incubated for 30 min with TS conjugated to FITC and co-stained with anti-CD
histograms of TS-FITCþ cells (line graph), compared with control thymocytes (so
cells gated on TS-FITCþ cells. Data are representative of three independent expermice stained strongly with the polyclonal anti-TS antibody.
This staining profile indicates that the trans-sialidase depots
are present near the parasite nests in the thymic tissue sur-
rounding the thymocytes.
These results raise the possibility that trans-sialidase binds
to the surfaces of differentiating thymocytes. This would have
an important effect on the biology of these cells as the parasite
enzyme has a lectin binding site besides its trans-sialidase
activity [17,22], which could promote signal transduction by
interacting with surface signaling receptors. Following this line
of reasoning, we decided to test whether the trans-sialidase
derived from T. cruziwas able to bind to the thymocyte surface.
Using FACS analysis we showed that FITC-labeled recombi-
nant parasite trans-sialidase bound to the surface of thymocytes
(Fig. 1B) obtained from normal thymus, with a staining profile
not restricted to any particular subset of cells (Fig. 1C).zi infection and its binding to thymocyte cells. BALB/c mice were injected
ain. At 15 days p.i., animals were killed and thymuses were removed for (A)
ialidase. Thymus sections from non-infected control mice were labeled with
ght panel). The insert is a higher magnification of an amastigote niche stained
six mice per group. To detect direct binding of TS to thymocyte surface, cells
4 and anti-CD8 mAbs prior to flow cytometry. Panel (B) depicts representative
lid gray). (C) Dot-plots show the percentages of double-positive CD4þCD8þ
iments.
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thymic atrophy and premature release of double-positive
CD4þCD8þ thymocytes to peripheral lymphoid organsThere is evidence that the T. cruzi trans-sialidase affects
nurse cell complexes and leads to apoptosis of thymocytes
undergoing differentiation inside the nurse cells. Importantly,
this phenomenon depends on the a-(2,3) sialyltransferase ac-
tivity of the trans-sialidase since it is not observed with the
inactive enzyme [16].
To see whether the trans-sialyltransferase plays a direct role
in the depletion of double-positive CD4þCD8þ thymocytes
in vivo, we injected mice intrathymically with 10 mg of re-
combinant trans-sialidase. Five days later, thymuses were
collected and viable cells were counted by trypan blue
exclusion, and the percentages of the various thymocyteFig. 3. Anti-TS antibody titers and frequency of the peripheral blood
CD4þCD8þ T cell subset in chronic chagasic patients. (A) Distribution of
anti-TS Ab in sera from non-infected individuals (NI), and patients with the
indeterminate (IND) and cardiac (CARD) forms of Chagas disease analyzed
by ELISA. Data are means  S.Ds. (B) Peripheral whole blood was analyzed
by four-color flow cytometry for expression of the CD3, CD4, CD8 markers.
The percentages of CD4þCD8þ cells on CD3þ T lymphocytes are indicated
for each histogram. Each point represents one subject. p < 0.05 (n ¼ 15 in-
dividuals per IND and CARD group; n ¼ 12 individuals per NI group).subsets were assessed by FACS analysis. As described for
acute T. cruzi infection, we found a significant reduction of the
proportion of DP T cells in the TS-injected mice as compared
to controls injected with PBS or the non-related BSA protein
(Fig. 2). Similar results were observed in TLR4-deficient
mice, thus excluding the possible effect of any contami-
nating LPS in the trans-sialidase preparation (Supplementary
Fig. 1).
Thymic atrophy in T. cruzi infections is correlated with an
increase in the population size of extrathymic immature thy-
mocytes [6,7]. We next asked whether the parasite enzyme
actually plays a role in the premature release of double-
positive CD4þCD8þ thymocytes to peripheral lymphoid or-
gans in chronic chagasic patients, and we obtained evidence of
a possible relationship between the presence of the trans-sia-
lidase as measured immunologically (Fig. 3A) and the fre-
quency of the peripheral blood DP cell subset (Fig. 3B) in
cross-sectional studies of patients with the indeterminate or
cardiac clinical forms of Chagas disease. There was a gradual
enhancement of the antibody titer against the parasite enzyme
as the percentage of DP cells in the peripheral blood of pa-
tients increased (Fig. 3).
Given this result, we next tested directly whether the
presence of the parasite trans-sialidase in the thymic micro-
environment interferes with thymopoiesis and leads to release
of undifferentiated thymocyte cells to the periphery. BALB/c
naı¨ve mice were intrathymically injected with FITC and T.
cruzi trans-sialidase (10 mg), and 24 h later FITC-labeled cells
appearing in the spleen were analyzed. We observed an in-
crease in the size of splenic CD4þCD8þ RTE population after
thymic injection of the trans-sialidase, with 30e40% of the
recent thymic emigrants (RTEs) representing DP cells (Fig. 4).
These results show that the increase in the peripheral DP T cellFig. 4. Intrathymic injection of T. cruzi trans-sialidase promotes the prema-
ture release of CD4þCD8þ double-positive T cells to the periphery. BALB/c
mice were intrathymically injected with an FITC solution containing 10 mg of
TS, or PBS only. After 24 h, spleen cells were stained with anti-CD4 and
anti-CD8 mAbs prior to flow cytometer analyzes. Histograms represent the
percentages of CD4þCD8þ T cells among recent thymic emigrants (RTEs)
obtained from the spleen. Data are means  S.D. (n ¼ 6 mice per group).
*P < 0.05.
Fig. 5. T. cruzi trans-sialidase activates the JNK MAPK pathway and actin rearrangement in thymocytes. Thymocytes were treated with T. cruzi TS for Western
blotting analysis probing with (A) anti-p-ERK and anti-p-JNK. In order to characterize actin filaments the cells were incubated with phalloidin-FITC (B) for
20 min after treatment with TS (left panels); DAPI was used for nuclear staining (middle panels); merged images (right panels). The results are representative of
three independent experiments.
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derives from thymocyte subpopulations that leave the thymus.3.3. Activation of JNK MAP kinases and actin
rearrangement in trans-sialidase-treated thymocytesAs the trans-sialidase has been shown to activate the
mitogen-activated protein kinase (MAPK) cascade in other
cell types [23], we tested whether the association of the T.
cruzi trans-sialidase with thymocytes also activated this
important signaling pathway involved in cell migration. To
this end, we first approached the activation of the classical
MAPK by western blot analysis with anti-phospho-MAP Ki-
nase1/2 (ERK1/2) and anti-phospho JNK monoclonal anti-
bodies. We observed no change in the profile of ERK
phosphorylation (Fig. 5A), but a marked increase in JNK
phosphorylation (Fig. 5A).
The JNK pathway plays crucial roles in cell adhesion and
migration, processes finely coordinated with remodeling of the
actin cytoskeleton [24,25]. Since adhesive and migratory re-
sponses are critical features of intrathymic T cell differentia-
tion and the export of mature T lymphocytes from the thymus
to peripheral tissues, we examined whether the events initiated
by T. cruzi trans-sialidase in thymocytes lead to actin filament
rearrangements. Using FITC-labeled phalloidin, which binds
to F-actin in the form of filaments or oligomers, we detected
polymerization of actin filaments in thymocytes upon treat-
ment with the parasite trans-sialidase; as shown in Fig. 5B, the
actin filaments in thymocytes treated with trans-sialidase have
a more homogenous distribution than in untreated thymocytesin which the filaments seem to be concentrated in the region of
contact between cells.3.4. T. cruzi trans-sialidase modulates the adhesive
behavior of thymocytes and increases their migration
toward extracellular matrix (ECM) moleculesSince our findings indicated that the T. cruzi trans-sialidase
promotes actin remodeling in thymocytes, an important
feature of cell adhesion and migratory responses, we next
investigated a possible effect of the parasite enzyme on
thymocytes-thymic epithelial cell (TEC) interactions during
thymocyte development. For this purpose, either thymocytes
or TECs were treated with the T. cruzi enzyme and then co-
cultured in the adhesion assay for 30 min at 37 C. When
the thymocytes were incubated with trans-sialidase, we found
a significant increase in the numbers of adhering thymocytes,
but this effect was not observed when instead the TECs were
pretreated with TS enzyme (Fig. 6A).
Since adhesion processes are required for thymocyte
migration during intrathymic development [26], we next
determined whether the T. cruzi enzyme affected the migration
of thymocytes toward the extracellular matrix. When we
measured thymocyte migration in transwell chambers pre-
coated with fibronectin, we found an increase in the number
of migrating cells if the thymocytes were first treated with the
parasite trans-sialidase (Fig. 6B). This treatment did not lead
to enhanced expression of fibronectin receptors on the thy-
mocytes, as we found no effect on the FACS staining profile of
VLA-4, VLA-5 and VLA-6 (data not shown). These findings
Fig. 6. T. cruzi trans-sialidase modulates adhesion and fibronectin-driven
migration of thymocytes. Thymocytes and/or TEC epithelial IT-76M1 cells
from BALB/c mice were incubated with 10 mg of TS for 30 min at 37 C.
Following treatment, thymocytes were allowed to adhere to TEC cultures for a
further 30 min. The plots show the association index for (A) TS treatment.
Data are means with S.E.M. of triplicate measurements of two representative
experiments and are expressed as association indexes calculated as follows:
Adhesion Index (AI) ¼ (TEC with bound thymocytes)/Total TEC
number  (thymocytes bound to TEC)/(Total TEC number)  100. (B)
Migratory responses were assessed in transwell chambers by adding thymo-
cytes to the upper chambers coated with fibronectin or BSA after TS treatment
for 30 min at 37 C. The cells were allowed to migrate for 3 h, and the number
of cells migrating toward fibronectin was assessed by subtracting the average
number of non-treated migrating cells obtained in wells coated with BSA.
Cells were counted in a flow cytometer. Data shown are mean with S.E.M. of
five representative experiments. *P < 0.05.
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ECM-mediated thymocyte migration, probably via signaling
processes that alter integrin affinity (‘activation’).
4. Discussion
Thymic atrophy is a feature of several infectious diseases
characterized by developmental disturbance of the intrathymic
thymocyte subpopulations and export of immature T cell [27].
In Chagas disease, it has been demonstrated that molecules
that are shed by the T. cruzi contribute to the thymic distur-
bances seen during infection. This is the case for the parasite-
derived trans-sialidase which promotes the intrathymic T celldeath by apoptosis induction in the nurse cell complex [16].
Nevertheless, a lack of a suitable explanation for the under-
lying mechanisms responsible for the premature release of
immature thymocytes in T. cruzi infection still remains.
In the present work we aimed to investigate the possible role
of the T. cruzi trans-sialidase in modifying the migratory re-
sponses of intrathymic thymocytes. We detected TS antigens in
the thymuses of acutely infected mice. Furthermore, we
showed that the parasite enzyme binds to the thymocyte surface
and injection of 10 mg of TS induced intense thymic atrophy
with thymocyte depletion, mainly of CD4þCD8þ cells, similar
to what occurs in the acute phase of experimental T. cruzi
infection. Although 10 mg is the amount produced by about 109
parasites [28], it is reasonable to suppose that an adequate level
of TS could be reached as a result of the cumulative effect of the
TS produced during the acute phase of infection, in which the
parasitemia peaks at about 106e107 parasites/ml of blood in
BALB/c mice in our experimental model [29]. Moreover, it has
been shown that the activity of exogenous TS-injected intra-
venously into uninfected BALB/c mice decays rapidly, prob-
ably as a result of breakdown, whereas TS activity stays high in
infected mice throughout the parasitemia [28].
Recently, it was possible to identify by mass spectrometry
in mouse thymocytes several cell surface acceptors of sialyl
residues in TS-catalyzed reactions [30]. Changes in the sia-
lylation profile of the cell surface receptors caused by TS
induced apoptosis in cells of the immune system in vivo,
including the thymus [15]. A detailed study of TS-treated
animals revealed that these effects were also a result of
apoptosis in the thymic nurse cell complexes [16]. The release
of undifferentiated CD4þCD8þ cells also accounts for thymic
atrophy [6,7,31]. Here we investigated whether the trans-sia-
lidase could also modulate the migratory responses of thy-
mocytes, which might account for the abnormal CD4þCD8þ
release from the thymus during infection.
Thymocyte migration is a crucial event in the intrathymic
differentiation of T cells [26]. It comprises several steps such
as entrance of bone marrow-derived precursors into the
thymus, traffic of immature thymocytes within the cortex and
from the cortex to the medulla, and finally, exit of these cells
from the organ [26,27]. All these processes require first the
adhesion and then de-adhesion of thymocytes from ECM
compounds onto TEC or microenvironmental components
[27,32]. Interestingly, we found that intrathymic trans-siali-
dase treatment increased the premature release of CD4þCD8þ
cells during thymic atrophy. We found an increased proportion
of CD4þCD8þ recent thymic emigrant (RTE) T cells
migrating to the peripheral lymphoid organs in the murine
model. In humans, our findings indicate a possible relationship
between the presence of trans-sialidase enzyme and the size of
the peripheral blood DP cell subset in chronic chagasic pa-
tients in the cardiac clinical forms of Chagas disease.
We showed that the parasite enzyme is able to activate the
JNK MAPK pathway in thymocytes. JNK plays a role in
regulating the cell migration of a broad range of cells [24,25].
Cell adhesion and migration require cytoskeleton structures
such as those formed by the actin network and cytoskeleton-
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are known to be JNK substrates [24,25,33]. In fact, our findings
indicate that the cell signaling events promoted by the trans-
sialidase result in mobilization of actin filaments. These
signaling events are activated in the interactions between TEC
and thymocytes, a required process for migratory dynamics of
thymocytes during the intrathymic development [34]. Here we
demonstrated that the T. cruzi TS increased thymocyte adhesion
to TEC. Interestingly, it should be pointed out that in order to
migrate, thymocytes must adhere to their microenvironment
and afterward de-adhere [26]. In this regard, molecules with
adhesive and de-adhesive properties may exert an important
function in modulating the migration [26,35]. In fact, our
findings indicated that in vitro thymocyte treatment with T.
cruzi TS resulted in an increased cell migration toward fibro-
nectin, indicating a role for this enzyme on this phenomenon.
In conclusion, our results show that T. cruzi trans-sialidase
induced thymic atrophy affects the dynamics of intrathymic
thymocytes resulting in an increase in the number of CD4þ8þ
double-positive recent thymic emigrants in the spleen.
Furthermore, we showed that TS is able to activate in thymo-
cytes MAPK JNK signaling and modulate thymocyte adhesion
to TECs and their migration toward the extracellular matrix.
These findings point to the possible involvement of parasite-
derived TS in the abnormal thymocyte trafficking within the
thymus of acutely T. cruzi-infected animals, which could in-
fluence the escape of immature thymocytes in Chagas disease.
We also found an increased frequency of DP T cells with high
antibody titles against the T. cruzi TS enzyme in chronic pa-
tients with the cardiac form of Chagas disease. The presence of
peripheral activated DP cells with potentially autoreactive TCR
may contribute to the immunopathological events found in this
disease. Our data support the potential utility of chemotherapy
approaches directed against the parasite TS in Chagas disease.Acknowledgments
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